Patent · US Expired

P. gingivalis antigenic composition

US7419671B2 · kind B2 · utility

14Cited by

6References

12Claims

0Family size

Assignees

CSL LIMITED · AU
The University of Melbourne · AU

Inventors

Eric Charles Reynolds · Melbourne, AU
Nada Slakeski · Melbourne, AU
Chao-Guang Chen · Melbourne, AU
Ian George Barr · Elmore, AU

Key dates

Filing date	Jun 18, 2002
Grant date	Sep 2, 2008
Priority date	—
Expiry date	Dec 29, 2022

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides an antigenic composition, the composition comprising at least one recombinant protein. The recombinant protein comprises at least one epitope. The epitope is reactive with an antibody which is reactive with a polypeptide having the sequence set out in SEQ. ID. NO. 3 or SEQ. ID. NO. 5. The invention also provides methods and compositions for the production of the recombinant protein. Also provided are methods for the diagnosis, treatment and prevention of P. gingivalis infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.